Travere Therapeutics (TVTX) Convertible Debt (2011 - 2026)
Travere Therapeutics (TVTX) posted Convertible Debt of $602.78 million for Q2 2026, up 93.8% from $311.02 million a year earlier and up 93.2% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Convertible Debt (2011 - 2026) Analysis & Trends
At the end of FY2025, Travere Therapeutics' Convertible Debt came in at $311.72 million, down 17.7% from FY2024.
- Annual Convertible Debt shows a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
- In prior years, Travere Therapeutics' Convertible Debt was $378.99 million in FY2024 (+0.5%), $377.26 million in FY2023 (+0.5%), $375.55 million in FY2022 (+65.7%) and $226.58 million in FY2021 (+5.2%).
- The Q2 2026 figure stands as the highest quarterly Convertible Debt in data going back to Q4 2011.
- On a year-over-year basis, Convertible Debt increased in four of the last eight quarters, with growth averaging 3.0%.
- The strongest year-over-year quarter for Convertible Debt in the past five years was Q2 2026, with growth of 93.8%; the weakest was Q4 2025, with a decline of 17.7%.
- According to Business Quant data, Convertible Debt for the three prior quarters was $312.08 million (Q1 2026), $311.72 million (Q4 2025) and $311.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Travere Therapeutics | 5.55 Bn | 5.14 Bn | 167.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 602.78 Mn |
| Mar 31, 2026 | 312.08 Mn |
| Dec 31, 2025 | 311.72 Mn |
| Sep 30, 2025 | 311.37 Mn |
| Jun 30, 2025 | 311.02 Mn |
| Mar 31, 2025 | 310.66 Mn |
| Dec 31, 2024 | 378.99 Mn |
| Sep 30, 2024 | 309.96 Mn |
| Jun 30, 2024 | 378.13 Mn |
| Mar 31, 2024 | 377.69 Mn |
| Dec 31, 2023 | 377.26 Mn |
| Sep 30, 2023 | 376.83 Mn |
| Jun 30, 2023 | 376.40 Mn |
| Mar 31, 2023 | 375.97 Mn |
| Dec 31, 2022 | 375.55 Mn |
| Sep 30, 2022 | 375.12 Mn |
| Jun 30, 2022 | 374.69 Mn |
| Mar 31, 2022 | 374.33 Mn |
| Dec 31, 2021 | 226.58 Mn |
| Sep 30, 2021 | 223.70 Mn |
API Access
Travere Therapeutics Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();